Study Group: Physicians who Treat Asthma (US)(?)
Council Members in this Study Group: 456
Request a survey with this Study Group
Leading Experts in this Study Group
Ass. Professor in Medicine
University of North Carolina at Chapel Hill School of Medicine - CC
Ray Coakley, MD PhD, is a physician scientist / pulmonary & critical care specialist at the University of North Carolina, Chapel Hill. His clinical and research focus is on COPD, cystic fibrosis, lung transplantation and PAH. Specific research expertise includes airway epithelial ion/fluid transport...
Robert Aris, MDAssociate Professor of Medicine
University of North Carolina Chapel Hill - CC
Robert Aris, MD, is an Associate Professor of Medicine at the University of North Carolina Chapel Hill. He is the Director of the Pulmonary Hypertension Program, the Lung Transplant Research Program and Inpatient Pulmonary Services. Dr. Aris has expertise in advanced lung diseases including cystic...
President
PSS Clinical Research
Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies, and Co-Director of two sleep disorders centers...
Associate Physician in Pulmonary and Critical Care
BRIGHAM AND WOMEN'S HOSPITAL
Michael Wechsler, MD, is an Associate Physician in the Pulmonary and Critical Care Division of Brigham and Women's Hospital in Boston and is on the faculty at Harvard Medical School. He is a member of the Steering Committee of the NIH's Asthma Clinical Research Network and is active in both basic and...
Michael Blaiss, MDPartner
Allergy & Asthma Care
Michael S. Blaiss, MD, is a Clinical Professor of Pediatrics and Medicine at University of Tennessee Health Sciences Center and in private practice at Allergy & Asthma Care in Memphis. Dr. Blaiss’s clinical focus is on allergies and has expertise in outcomes research in allergic disorders, especially...
Dean Traiger, MDPhysician
Physicians’ Primary Care of Southwest Florida,P.L.
Dean Traiger, MD, is the Owner of Physician's Primary Care of Southwest Florida. Dr. Traiger is board certified in Family Practice and specializes in general primary care across the continuum of pediatrics, adolescent, and adult and geriatric care. He is also focused on diabetes care, hypertension,...
Allergist & Immunologist
Institute for Asthma and Allergy
H. Henry Li, MD, PhD, is board certified in Allergy and Immunology. Dr. Li received his Allergy and Clinical Immunology training from Johns Hopkins Hospital, where he remains as medical faculty since 2001. In 2002, he joined the Institute for Asthma and Allergy in Chevy Chase, MD. Dr. Li received his...
Assistant Clinical Professor
Albert Einstein College of Medicine
Mitchell Boxer, MD, is Director of the Adult Allergy Section at Long Island Jewish Medical Center and Assistant Clinical Professor at Albert Einstein Medical College. Dr. Boxer completed his fellowship at Northwestern University Medical College and has expertise in a wide range of allergic and immunologic...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Pulmonologists (US) | 752 |
| Allergists (US) | 401 |
| Physicians in the U.S. who Treat Chronic Obstructive Pulmonary Disease (COPD) | 215 |
| Immunologists (US) | 376 |
| Pediatricians (US) | 1667 |
| Critical Care Physicians | 750 |
| Physicians who Treat Insomnia (US) | 514 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
I agree with the premise of the article -- that diuretics may be underutilized as a cheap way to get the benefits of antihypertensives. However, more than 40% of my HTN patients are on diuretics, and I think the data presented in the NY Times article may be flawed. Here's why:
This phase III study was done without the benefit of conventional drug development with Phase I and Phase II studies (which would have provided more information about the effective dose) preceding it because pharmacokinetic date from IV and SC dosing studies were used to extrapolate for the...
In a recent article it is noted that for users of Ipatropium bromide there was an increase in all death and cardiac death in the group studied. Theoretically at doses normally used there is not much of a corresponding mechanistic risk. Therefore at this time additional study must be done...
If truly an association, this will alter the use of this drug.
DDP4 inhibitor class fairly new. Another arrow in the theraputic quiver
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Physician - Division Head
- President
- Director
- Partner
- Medical Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

